Literature DB >> 667033

Erythrocyte lipid composition and sodium transport in human liver disease.

J S Owen, N McIntyre.   

Abstract

In patients with liver disease there are usually increases in erythrocyte cholesterol and phosphatidylcholine concentrations. This increase in membrane lipid changes the shape of the erythrocyte and "spur" or "target" cells may be present. Sodium fluxes were measured in erythrocytes from 17 patients with a variety of liver diseases and from 17 normal subjects and the values related to the lipid content of the membrane. Ouabain-insensitive and ouabain-sensitive effluxes were lower in patients than in normal subjects and the reduction in ouabain-insensitive efflux was more marked. Sodium influx was also significantly lower in erythrocytes from patients than controls. Ouabain-sensitive and ouabain-insensitive effluxes and sodium influx did not correlate with the cholesterol content of erythrocytes from patients. Significant negative correlations were noted between ouabain-insensitive sodium efflux (r=--0.63, P less than 0.01), sodium influx (r=--0.61, P less than 0.01) and intracellular sodium concentration (r=--0.66, P less than 0.01) and the cholesterol : phospholipid molar ratio of the cell but there was no significant correlation between this ratio and the ouabain-sensitive sodium efflux (r=0.41, P less than 0.05). These results support the hypothesis that an altered lipid composition may affect the permeability of the erythrocyte membrane in patients with liver disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667033     DOI: 10.1016/0005-2736(78)90138-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Changes in lipid composition of erythrocyte membranes with administration of S-adenosyl-L-methionine in chronic liver disease.

Authors:  H Kakimoto; S Kawata; Y Imai; M Inada; Y Matsuzawa; S Tarui
Journal:  Gastroenterol Jpn       Date:  1992-08

Review 2.  Extrahepatic cell membrane lipid abnormalities and cellular dysfunction in liver disease.

Authors:  J S Owen
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis, before and after Treatment with Direct Antiviral Agents: A pilot Study.

Authors:  Charalampos Papadopoulos; Maria Panopoulou; Theodora Mylopoulou; Konstantinos Mimidis; Ioannis Tentes; Konstantinos Anagnostopoulos
Journal:  Maedica (Bucur)       Date:  2020-06

4.  In vivo intermembrane transfer of phospholipids in the photosynthetic bacterium Rhodopseudomonas sphaeroides.

Authors:  B D Cain; C D Deal; R T Fraley; S Kaplan
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

5.  Interaction of phenol-soluble modulins with phosphatidylcholine vesicles.

Authors:  Anthony C Duong; Gordon Y C Cheung; Michael Otto
Journal:  Pathogens       Date:  2012-07-20

6.  Lipidomics Indicates the Hepatotoxicity Effects of EtOAc Extract of Rhizoma Paridis.

Authors:  Chaofeng Li; Mingshuang Wang; Tingting Fu; Zhiqi Li; Yang Chen; Tao He; Dan Feng; Zhaoyi Wang; Qiqi Fan; Meilin Chen; Honggui Zhang; Ruichao Lin; Chongjun Zhao
Journal:  Front Pharmacol       Date:  2022-02-08       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.